Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Atogepant

Copy Product Info
😃Good
Catalog No. T26682Cas No. 1374248-81-3
Alias MK8031. Atogepant, MK-8031, MK 8031, AGN-241689, AGN241689

Atogepant (MK-8031) is an orally available, selective and potent calcitonin gene-related peptide receptor (CGRP) antagonist for the study of migraine.

Atogepant

Atogepant

Copy Product Info
😃Good
Purity: 99.66%
Catalog No. T26682Alias MK8031. Atogepant, MK-8031, MK 8031, AGN-241689, AGN241689Cas No. 1374248-81-3
Atogepant (MK-8031) is an orally available, selective and potent calcitonin gene-related peptide receptor (CGRP) antagonist for the study of migraine.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$158In StockIn Stock
5 mg$278In StockIn Stock
10 mg$347In StockIn Stock
25 mg$689In StockIn Stock
50 mg$1,230-In Stock
100 mg$1,790-In Stock
200 mg$2,420-In Stock
1 mL x 10 mM (in DMSO)$372In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.66%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Atogepant (MK-8031) is an orally available, selective and potent calcitonin gene-related peptide receptor (CGRP) antagonist for the study of migraine.
Targets&IC50
CGRP receptors (mouse):0.13 nM (Ki), CGRP receptors (rat):0.7 nM (Ki), CGRP receptors (rhesus macaque):0.009 nM (Ki), CGRP receptors (rabbit):2.1 nM (Ki), CGRP (human cloned):0.026 nM, CGRP receptors (human natural):0.026 nM (Ki), CGRP receptors (dog):1.2 nM (Ki), CGRP receptors (human cloned):0.015 nM (Ki)
In vitro
Atogepant has a CGRP IC50=0.026 nM for human clones.
The binding affinities of Atogepant for human and non-human CGRP receptors were: human (cloned) Ki=0.015 nM, human (natural) Ki=0.026 nM, rhesus macaque Ki=0.009 nM, rat Ki=0.7 nM, mouse Ki=0.13 nM, rabbit Ki=2.1 nM, dog Ki=1.2 nM, respectively. [1][2]
In vivo
Oral administration of Atogepant to rats (at doses of 3, 10, and 30 mg/kg, respectively) once daily for 9 days showed that Atogepant effectively attenuated the abnormal facial pain induced by nitroglycerin and ameliorated the capsaicin-induced vasodilation of primate dermis in rats.[2]
SynonymsMK8031. Atogepant, MK-8031, MK 8031, AGN-241689, AGN241689
Chemical Properties
Molecular Weight603.52
FormulaC29H23F6N5O3
Cas No.1374248-81-3
SmilesO=C1[C@@]2(C=3C(N1)=NC=CC3)CC=4C(C2)=NC=C(C(N[C@H]5C[C@H]([C@@H](C)N(CC(F)(F)F)C5=O)C6=C(F)C(F)=CC=C6F)=O)C4
Relative Density.1.54 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (132.56 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.6569 mL8.2847 mL16.5695 mL82.8473 mL
5 mM0.3314 mL1.6569 mL3.3139 mL16.5695 mL
10 mM0.1657 mL0.8285 mL1.6569 mL8.2847 mL
20 mM0.0828 mL0.4142 mL0.8285 mL4.1424 mL
50 mM0.0331 mL0.1657 mL0.3314 mL1.6569 mL
100 mM0.0166 mL0.0828 mL0.1657 mL0.8285 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Atogepant | purchase Atogepant | Atogepant cost | order Atogepant | Atogepant chemical structure | Atogepant in vivo | Atogepant in vitro | Atogepant formula | Atogepant molecular weight